Clinical trial ROSALINE
Neoadjuvante studie met gerichte therapie tegen Ros1 in combinatie met endocriene therapie in invasief lobulair borstcarcinoom
| Kankers | |
|---|---|
| Organ | Borst |
| Trial status | Trial afgesloten |
| Investigator(s) | |
| Trial type |
Interventioneel met experimenteel geneesmiddel
|
| Fase | Fase van de proef 2 |
| Academisch proef | Ja |
| Sponsor | Institut Jules Bordet |
| EudraCT Identifier | 2019-004942-14 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04551495 |
| Laatste update |